Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach
Sign Up to like & getrecommendations! Published in 2020 at "Computers in Biology and Medicine"
DOI: 10.1016/j.compbiomed.2020.103848
Abstract: Abstract The recent outbreak of coronavirus disease-19 (COVID-19) continues to drastically affect healthcare throughout the world. To date, no approved treatment regimen or vaccine is available to effectively attenuate or prevent the infection. Therefore, collective… read more here.
Keywords: potential inhibitors; drug; inhibitors three; identification potential ... See more keywords
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)
Sign Up to like & getrecommendations! Published in 2023 at "Haemophilia"
DOI: 10.1111/hae.14762
Abstract: The UK National Haemophilia Database (NHD) collects data from all UK persons with haemophilia A with inhibitors (PwHA‐I). It is well‐placed to investigate patient selection, clinical outcomes, drug safety and other issues not addressed in… read more here.
Keywords: prophylaxis haemophilia; haemophilia inhibitors; inhibitors three; emicizumab prophylaxis ... See more keywords
Safety of SGLT2 Inhibitors in Three Chronic Diseases.
Sign Up to like & getrecommendations! Published in 2023 at "International heart journal"
DOI: 10.1536/ihj.22-441
Abstract: This study aimed to assess the safety of SGLT2 inhibitors in type 2 diabetes, chronic kidney disease, and chronic heart failure considering the number needed to treat (NNT).Methods: Data were obtained from 10 morbidity-mortality trials… read more here.
Keywords: safety; inhibitors three; kidney; safety sglt2 ... See more keywords